CEO Takes 57% Control Of Diagnostics Co. After $291M Offer
The chief executive of London-listed Integrated Diagnostics now holds just under 57% of the shares in the company after launching a mandatory $290.7 million cash takeover in June, the company said...To view the full article, register now.
Already a subscriber? Click here to view full article